The largest study to date of magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor identified a target area within the ventral intermediate nucleus (VIM) that could […]

We’ve long known that migraine is an insidious disease. Patients with a variety of existing illnesses — atopic disorders, cardiovascular diseases, and sleep and/or psychiatric disorders […]

(Reuters) -The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals’ self-administered migraine drug, giving way to a quick and more convenient treatment option for patients. […]

What has been described as a mysterious neurologic syndrome of unknown cause (NSUC) in the Canadian province of New Brunswick is a “perfect storm” of “misdiagnosis, […]

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation decisions, a […]

The clinical utility of the calcitonin gene–related peptide (CGRP) receptor antagonist ubrogepant may extend beyond the treatment of acute migraine to alleviating common prodromal symptoms of […]